Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001705095 | SCV000249827 | likely benign | not provided | 2019-12-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311039 | SCV000319821 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-09-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002229053 | SCV000631512 | likely benign | Ehlers-Danlos syndrome, classic type, 1 | 2025-01-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003907716 | SCV004722951 | likely benign | COL5A1-related disorder | 2019-06-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |